Evidence map›Paper›PMID 28192490›Full record

ArticlePloS one2017

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.

Fan-Ya Meng, Yong Sun, Yong-Gang Shen, Hai-Feng Pan, Ji-Hai Tang, Bin-Bing Wang, Chang-Hao Wu, Dong-Qing Ye

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fan-Ya MengDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Yong SunDepartment of Immunization and Prevention, Anhui Center for Disease Control and Prevention, Hefei, Anhui, China.
Yong-Gang ShenDepartment of Immunization and Prevention, Anhui Center for Disease Control and Prevention, Hefei, Anhui, China.
Hai-Feng PanDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Ji-Hai TangDepartment of Immunization and Prevention, Anhui Center for Disease Control and Prevention, Hefei, Anhui, China.
Bin-Bing WangDepartment of Immunization and Prevention, Anhui Center for Disease Control and Prevention, Hefei, Anhui, China.
Chang-Hao WuFaculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
Dong-Qing YeDepartment of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.

Funding

Nox Enzymes in Aging Bladder DysfunctionR01AG049321 · NIA · TEMPLE UNIV OF THE COMMONWEALTH · PI BARBE, MARY F · 2016 to 2020
$1.7M
NIA NIH HHS R01 AG049321
6 · The paper itself

Abstract

The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live attenuated measles vaccine, live attenuated measles and rubella combined vaccine, live attenuated measles and mumps combined vaccine, live attenuated Measles, Mumps and Rubella Combined Vaccine) in Anhui Province, China. From 2009 to 2014, 9.9 million doses of measles-containing vaccines were administrated and 1893 AEFIs were found (191.4 per million doses), of which, 33 serious AEFIs (3.3 per million vaccine doses) were reported. 59.4% (1124 cases) were male cases, and 85.1% (1611 cases) occurred in persons aged < 1 year. 93.3% (1766 cases) occurred at the first dose of vaccination and 95.9% (1815 cases) were found within 3 days after vaccination. This study presents up-to-date data and suggests that the measles-containing vaccines used in Anhui Province of China are safe.

Indexed as

Adverse Drug Reaction Reporting SystemsAnaphylaxisAsian PeopleChinaDrug-Related Side Effects and Adverse ReactionsEncephalitisHumansImmunizationMeaslesMeasles-Mumps-Rubella VaccineMeasles VaccineProduct Surveillance, PostmarketingSeizuresThrombocytopeniaVaccines, AttenuatedVaccines, CombinedMeasles-Mumps-Rubella VaccineMeasles VaccineVaccines, AttenuatedVaccines, Combined

Identifiers

PMID28192490
PMCPMC5305249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.